journey to transplant: how patients facing organ failure get on the transplant waiting list
DESCRIPTION
Journey to Transplant: How Patients Facing Organ Failure Get on the Transplant Waiting List. Christine Lee, RN, BSN, CCTC Leeanne Shinn, RN UCLA Kidney and Pancreas Transplant Program. “How To Be”. Being in Action! The Answers Are In the Room “Report out” on Questions to Run-on: Scribe - PowerPoint PPT PresentationTRANSCRIPT
Journey to Transplant:Journey to Transplant:How Patients Facing Organ How Patients Facing Organ
Failure Get on the Transplant Failure Get on the Transplant Waiting ListWaiting List
Christine Lee, RN, BSN, CCTC
Leeanne Shinn, RN
UCLA Kidney and Pancreas Transplant Program
““How To Be”How To Be”
Being in Action!
The Answers Are In the Room
“Report out” on Questions to Run-on: – Scribe – Spokesperson
All Teach / All Learn
Question to Run on?Question to Run on?
What can you do to educate your patients or community on the Journey to Transplant?
IntroductionsIntroductions
Christine Lee
Leeanne Shinn
ObjectivesObjectives
Understand the referral, evaluation and listing process for organ transplant – kidney transplantation
Provide overview of the national wait list and review various deceased donor options
Discuss living donor transplant options
Treatment OptionsTreatment Options
– Heart/Lung/Liver failure: Organ transplant Heart - LVAD as bridge to transplant
– End stage renal disease (ESRD): Dialysis Kidney Transplant
– Type 1 diabetes: Insulin therapy Pancreas alone (PA), kidney/pancreas
transplant (SPK)
What is the goal of kidney transplant?What is the goal of kidney transplant?
Freedom from dialysis Better quality of lifeProlongs life compared to dialysisTo maximize survival
Fig. 1. Overall unadjusted actuarial survival probabilities for transplanted recipients and haemodialysis patients
Mazzuchi, N. et al. Nephrol. Dial. Transplant. 1999 14:2849-2854; doi:10.1093/ndt/14.12.2849
Kidney TransplantKidney Transplant
Cons:– Not for everyone: compliance, health– Long wait time due to organ shortage– Require strict adherence to daily
medications– Transplant medications for life
Referral ProcessReferral Process
For kidney transplant - Referral made by physician, dialysis social worker, insurance case manager or patient
Find a local transplant program Necessary documents:
– H&P, Social worker note, most recent lab, cardiac tests, imaging studies, ABO
– Medicare Entitlement Form (2728 form)
Schedule an appointment with the transplant team for evaluation
Selecting a Transplant ProgramSelecting a Transplant Program The experience of the transplant team Insurance coverage Geographical proximity to the program
– The travel time to the transplant center is important when patient is waiting for an organ and is a key factor considered in organ distribution.
The quality and availability of pre- and post-transplant services.
Availability of friends and family for assistance
Evaluation ProcessEvaluation Process
Patient Education Orientation Consultation with the transplant team
– Transplant Physician– Surgeon– Transplant Nurse Coordinator– Social Worker– Dietician
Evaluation ProcessEvaluation Process
Other consultation as needed– Cardiology, Hepatology, Infectious Disease, Psychiatry,
Hematology, Dermatology, Oncology, etc Pending tests
– Lab: Blood type x2, HLA, PRA, serology– Cardiac tests: EKG, Stress test, Echocardiogram, Coronary
angiogram– Radiology: CXR, renal/abdominal ultrasound, CT scan, MRI– Screening tests: PSA, pap smear, mammogram,
colonoscopy
Patient Selection CriteriaPatient Selection Criteria Must be accepted as a candidate before listing Selection Criteria
– In general, all end-stage renal failure patients who, after having been informed of the risks of the transplant surgery and the inevitable chronic immunosuppressive therapy, still express a clear desire for this modality of treatment, will be accepted as candidates for evaluation.
Exclusion criteria– Presence of disseminated or recent malignancy– Active infection– Severe coronary artery disease and/or peripheral vascular disease– Underlying disease states such as multiple myeloma, scleroderma, oxalosis, sickle-
cell anemia– Serious psychosocial problems– Squamous cell skin cancer– Renal cell carcinomas– BMI > 35– Partial insurance coverage– Patients that are wheelchair bound, require oxygen, or are severely disabled– Patients who are unwilling to accept blood transfusions under any circumstances while
taking anticoagulations
Patient Selection CriteriaPatient Selection Criteria
After completion of the workup, Selection Committee will review the case
The Committee is made up of Transplant Nephrologists, Surgeons, Nurse Coordinators, Social workers, dietician, pharmacist and other consultants
Once decision is made, the patient and physician will be notified in writing
Listing ProcessListing Process
Medical clearance by the Selection Committee
Financial clearance Eligibility for wait time accrual
– On maintenance dialysis– GFR 20 or less
Notification within 10 days to the patient, physician and dialysis social worker
UNOS Wait ListUNOS Wait List
National Wait List - United Network for Organ Sharing (UNOS)
107,337 patients are waiting for all organs
84,000+ patients are waiting for kidney transplant
U.S. Waiting List Candidates by OrgansU.S. Waiting List Candidates by Organs
Based on current OPTN data as reported on May 7, 2010. Data subject to change based on future data submission or correction.
UNOS Wait ListUNOS Wait List
About 16,000 transplants per year– 6,000 living donor transplant (doubled over
15 yrs)– 10,000 deceased donor
California Wait List– 16,250+ patients are waiting for kidney– Average wait time: 7 to 10 years
Allocation StrategiesAllocation Strategies
Dialysis Wait Time: – wait time starts as initial dialysis start date
Dual organ transplant – kidney/pancreas– Liver/Kidney– Heart/Kidney
Multiple listing
Is there a way to reduce the Is there a way to reduce the waiting time? waiting time?
Expanded Criteria Donor (ECD) kidney– A kidney from a donor age over 60 years or over age 50 with a history of HTN, cause of death due to
CVA, or a terminal creatinine greater than 1.5 mg/d
Hepatitis C list– Only for the patients with hepatitis C
Donation after cardiac death (DCD)– A kidney from a donor who was declared dead based on a lack of a heartbeat. – These kidneys are less likely to function immediately & may have a greater risk of rejection
The Centers for Disease Control (CDC) increased risk – Higher risk for the transmission of viral disease including HIV & Hepatitis
Donation Point
Living Donor Transplant
Living Donor Transplant Living Donor Transplant OptionsOptions
Compatible Recipient-Donor pairs Desensitization Protocols Blood Type incompatible Kidney Exchange Program
– AKA Paired Exchange or Chain Transplant
ESRD Patient
Living Donor
No Yes
Deceased DonorWaiting List
Standard CriteriaWaiting List
Transplant
HCV+
HCV + List
Transplant
>50
ECD List
Transplant
Blood TypeCompatible Incompatible
Crossmatch-
DonorWorkup
Transplant
+
Investigate Other Donors
+
Crossmatch+ -
Transplant
-
DesensitizationProtocol
Transplant
Evaluate Anti-A/B Titers
Low
Crossmatch
ABOiProtocol
Transplant
High
Paired ExchangeProgram
Crossmatch
Transplant
Low titer but donor ptinterested in paired
exchange
Single dose
Transplant
Multi-dose
MCS
Algorithm of UCLA Renal Failure Patients Awaiting Transplantation
Patient Preference
(Patient remains on deceased donor list)
AltruisticDonor
G. Lipshutz 3/2008
Living DonationLiving Donation
Related vs. UnrelatedRequirements
– Age 18 ~ 65– Health Concerns (diabetes, high
blood pressure, cancer, hepatitis, weight issue)
– Lifestyle: substance abuse
Blood type compatibility chartBlood type compatibility chart
Candidate’s Blood Type
O
A
B
AB
Donor’s Blood Type
O
A or O
B or O
A, B, AB or O
Compatible Recip-Donor PairsCompatible Recip-Donor Pairs
Blood types are compatibleCross match testing indicates low risk of
early rejectionDonor can donate directly to recipient
But…But…
What if the donor and the recipient
are not compatible?
•At least one third of patients with a willing living donor are excluded due to incompatible blood type and positive cross match
•35% of any two people will be blood type incompatible•30 % of patients needing a kidney transplant will be sensitized because of previous transplants, pregnancies or transfusions
DesensitizationDesensitization
Advantages include increasing the donor pool and the friend or love one can donate to the intended recipient
Disadvantages include cost which averages approximately $30,000
Decreased patient survival (5yr 87% vs. 94%) AJT 2004
Unpredictable rates of accelerated rejection Decreased graft survival (1yr. 84% vs. 96% ) AJT
2004 Decreased 5 yr. graft survival (69% vs. 81%) AJT
2009
Blood Type IncompatibleBlood Type Incompatible
Living donor has different blood type No other donor available Requires analysis of antibody levels Insurance authorization for treatment Pre-operative treatment protocol over several
weeks to achieve safe window for transplantation with your living donor
ABOiABOi
Molecules present or absent on blood cells determine blood type
When blood types are mixed, these molecules act as antigens that trigger ABO incompatibility reaction
Preconditioning is done to cleanse the blood of these circulating antibodies and depends on blood type and amount of antibodies present
ABOi TherapiesABOi Therapies
Plasmapheresis- remove antibodiesImmunoglobulin-decrease antibodies
which are destructive to the graftSplenectomyAnti-CD20 Antibody (rituximab)-
depletes CD20 protein which is found on the wall of most B cells
Paired DonationPaired Donation
Initially slow to take off because 1984 NOTA “unlawful to acquire organ in exchange for valuable consideration”
2007 Senate bill “valuable consideration does not apply to paired donation”
Donor ExchangeDonor Exchange
Recipient/donor pair have incompatible blood types
Other donor/recipient pair have incompatible blood types
Donors evaluated/accepted for donation Donor/recipient pairs “exchange” donor
kidneys Exchange is anonymous until after surgery
Paired donor exchangePaired donor exchange
Pair #1
Recip blood type = A
Donor blood type = B
B to A is not compatible
Pair #2
Recip blood type = B
Donor blood type = A
A to B is not compatible
Paired Donor ExchangePaired Donor Exchange
Pair #1 Pair #2
Recipient = A Recipient = B
Donor = B Donor = A
Blood-type incompatible Recip/Donor pairs
exchange blood-type compatible kidneys
Down Side of Paired DonationDown Side of Paired Donation
If one living donor backs out then the other pair is disadvantaged
Requires simultaneous O.R. start
Donor Exchange “Chains”Donor Exchange “Chains”
Participation of multiple pairs of donors and recipients
Usually started by a non-directed or “altruistic”
One donor is “left over” to begin a new section of the chain
Donor ChainsDonor Chains
Living donor can donate local to where they live
Kidneys are shipped using established OPO protocols on commercial flights
Do not need simultaneous O.R. start times
Donor ChainsDonor Chains
Very time intensive, high work load for low yield
Only about 120 done to datePotential for 1,000 -2,000 additional
kidney transplants per yearIf there is a delay in donation, donor
may back out
In short, there are new optionsIn short, there are new options
“Standard” living donor transplantHighly-sensitizedBlood-type incompatiblePaired or triple exchangeDonor exchange “chains”
ConclusionConclusion
Timely referral to transplant center Communication and collaboration between
the referring physician, patient, dialysis unit and the transplant team are the key
Advances in living donation are providing patients with more opportunities for transplant
Question to Run on?Question to Run on?
What can you do to educate your patients or community on the Journey to Transplant?
3 minutes to work at your tables and report back, Go!
Transition to Transition to Breakout Session #2Breakout Session #2
Next Breakout Session starts at 11:30
Please see your agenda for specific room locations
Enjoy the Learning!
Journey to Transplant:Journey to Transplant:How Patients Facing Organ How Patients Facing Organ
Failure Get on the Transplant Failure Get on the Transplant Waiting ListWaiting List
Christine Lee, RN, BSN, CCTC
Leeanne Shinn, RN
UCLA Kidney and Pancreas Transplant Program
““How To Be”How To Be”
Being in Action!
The Answers Are In the Room
“Report out” on Questions to Run-on: – Scribe – Spokesperson
All Teach / All Learn
Question to Run on?Question to Run on?
What can you do to educate your patients or community on the Journey to Transplant?
IntroductionsIntroductions
Christine Lee
Leeanne Shinn
ObjectivesObjectives
Understand the referral, evaluation and listing process for organ transplant – kidney transplantation
Provide overview of the national wait list and review various deceased donor options
Discuss living donor transplant options
Treatment OptionsTreatment Options
– Heart/Lung/Liver failure: Organ transplant Heart - LVAD as bridge to transplant
– End stage renal disease (ESRD): Dialysis Kidney Transplant
– Type 1 diabetes: Insulin therapy Pancreas alone (PA), kidney/pancreas
transplant (SPK)
What is the goal of kidney transplant?What is the goal of kidney transplant?
Freedom from dialysis Better quality of lifeProlongs life compared to dialysisTo maximize survival
Fig. 1. Overall unadjusted actuarial survival probabilities for transplanted recipients and haemodialysis patients
Mazzuchi, N. et al. Nephrol. Dial. Transplant. 1999 14:2849-2854; doi:10.1093/ndt/14.12.2849
Kidney TransplantKidney Transplant
Cons:– Not for everyone: compliance, health– Long wait time due to organ shortage– Require strict adherence to daily
medications– Transplant medications for life
Referral ProcessReferral Process
For kidney transplant - Referral made by physician, dialysis social worker, insurance case manager or patient
Find a local transplant program Necessary documents:
– H&P, Social worker note, most recent lab, cardiac tests, imaging studies, ABO
– Medicare Entitlement Form (2728 form)
Schedule an appointment with the transplant team for evaluation
Selecting a Transplant ProgramSelecting a Transplant Program The experience of the transplant team Insurance coverage Geographical proximity to the program
– The travel time to the transplant center is important when patient is waiting for an organ and is a key factor considered in organ distribution.
The quality and availability of pre- and post-transplant services.
Availability of friends and family for assistance
Evaluation ProcessEvaluation Process
Patient Education Orientation Consultation with the transplant team
– Transplant Physician– Surgeon– Transplant Nurse Coordinator– Social Worker– Dietician
Evaluation ProcessEvaluation Process
Other consultation as needed– Cardiology, Hepatology, Infectious Disease, Psychiatry,
Hematology, Dermatology, Oncology, etc Pending tests
– Lab: Blood type x2, HLA, PRA, serology– Cardiac tests: EKG, Stress test, Echocardiogram, Coronary
angiogram– Radiology: CXR, renal/abdominal ultrasound, CT scan, MRI– Screening tests: PSA, pap smear, mammogram,
colonoscopy
Patient Selection CriteriaPatient Selection Criteria Must be accepted as a candidate before listing Selection Criteria
– In general, all end-stage renal failure patients who, after having been informed of the risks of the transplant surgery and the inevitable chronic immunosuppressive therapy, still express a clear desire for this modality of treatment, will be accepted as candidates for evaluation.
Exclusion criteria– Presence of disseminated or recent malignancy– Active infection– Severe coronary artery disease and/or peripheral vascular disease– Underlying disease states such as multiple myeloma, scleroderma, oxalosis, sickle-
cell anemia– Serious psychosocial problems– Squamous cell skin cancer– Renal cell carcinomas– BMI > 35– Partial insurance coverage– Patients that are wheelchair bound, require oxygen, or are severely disabled– Patients who are unwilling to accept blood transfusions under any circumstances while
taking anticoagulations
Patient Selection CriteriaPatient Selection Criteria
After completion of the workup, Selection Committee will review the case
The Committee is made up of Transplant Nephrologists, Surgeons, Nurse Coordinators, Social workers, dietician, pharmacist and other consultants
Once decision is made, the patient and physician will be notified in writing
Listing ProcessListing Process
Medical clearance by the Selection Committee
Financial clearance Eligibility for wait time accrual
– On maintenance dialysis– GFR 20 or less
Notification within 10 days to the patient, physician and dialysis social worker
UNOS Wait ListUNOS Wait List
National Wait List - United Network for Organ Sharing (UNOS)
107,337 patients are waiting for all organs
84,000+ patients are waiting for kidney transplant
U.S. Waiting List Candidates by OrgansU.S. Waiting List Candidates by Organs
Based on current OPTN data as reported on May 7, 2010. Data subject to change based on future data submission or correction.
UNOS Wait ListUNOS Wait List
About 16,000 transplants per year– 6,000 living donor transplant (doubled over
15 yrs)– 10,000 deceased donor
California Wait List– 16,250+ patients are waiting for kidney– Average wait time: 7 to 10 years
Allocation StrategiesAllocation Strategies
Dialysis Wait Time: – wait time starts as initial dialysis start date
Dual organ transplant – kidney/pancreas– Liver/Kidney– Heart/Kidney
Multiple listing
Is there a way to reduce the Is there a way to reduce the waiting time? waiting time?
Expanded Criteria Donor (ECD) kidney– A kidney from a donor age over 60 years or over age 50 with a history of HTN, cause of death due to
CVA, or a terminal creatinine greater than 1.5 mg/d
Hepatitis C list– Only for the patients with hepatitis C
Donation after cardiac death (DCD)– A kidney from a donor who was declared dead based on a lack of a heartbeat. – These kidneys are less likely to function immediately & may have a greater risk of rejection
The Centers for Disease Control (CDC) increased risk – Higher risk for the transmission of viral disease including HIV & Hepatitis
Donation Point
Living Donor Transplant
Living Donor Transplant Living Donor Transplant OptionsOptions
Compatible Recipient-Donor pairs Desensitization Protocols Blood Type incompatible Kidney Exchange Program
– AKA Paired Exchange or Chain Transplant
ESRD Patient
Living Donor
No Yes
Deceased DonorWaiting List
Standard CriteriaWaiting List
Transplant
HCV+
HCV + List
Transplant
>50
ECD List
Transplant
Blood TypeCompatible Incompatible
Crossmatch-
DonorWorkup
Transplant
+
Investigate Other Donors
+
Crossmatch+ -
Transplant
-
DesensitizationProtocol
Transplant
Evaluate Anti-A/B Titers
Low
Crossmatch
ABOiProtocol
Transplant
High
Paired ExchangeProgram
Crossmatch
Transplant
Low titer but donor ptinterested in paired
exchange
Single dose
Transplant
Multi-dose
MCS
Algorithm of UCLA Renal Failure Patients Awaiting Transplantation
Patient Preference
(Patient remains on deceased donor list)
AltruisticDonor
G. Lipshutz 3/2008
Living DonationLiving Donation
Related vs. UnrelatedRequirements
– Age 18 ~ 65– Health Concerns (diabetes, high
blood pressure, cancer, hepatitis, weight issue)
– Lifestyle: substance abuse
Blood type compatibility chartBlood type compatibility chart
Candidate’s Blood Type
O
A
B
AB
Donor’s Blood Type
O
A or O
B or O
A, B, AB or O
Compatible Recip-Donor PairsCompatible Recip-Donor Pairs
Blood types are compatibleCross match testing indicates low risk of
early rejectionDonor can donate directly to recipient
But…But…
What if the donor and the recipient
are not compatible?
•At least one third of patients with a willing living donor are excluded due to incompatible blood type and positive cross match
•35% of any two people will be blood type incompatible•30 % of patients needing a kidney transplant will be sensitized because of previous transplants, pregnancies or transfusions
DesensitizationDesensitization
Advantages include increasing the donor pool and the friend or love one can donate to the intended recipient
Disadvantages include cost which averages approximately $30,000
Decreased patient survival (5yr 87% vs. 94%) AJT 2004
Unpredictable rates of accelerated rejection Decreased graft survival (1yr. 84% vs. 96% ) AJT
2004 Decreased 5 yr. graft survival (69% vs. 81%) AJT
2009
Blood Type IncompatibleBlood Type Incompatible
Living donor has different blood type No other donor available Requires analysis of antibody levels Insurance authorization for treatment Pre-operative treatment protocol over several
weeks to achieve safe window for transplantation with your living donor
ABOiABOi
Molecules present or absent on blood cells determine blood type
When blood types are mixed, these molecules act as antigens that trigger ABO incompatibility reaction
Preconditioning is done to cleanse the blood of these circulating antibodies and depends on blood type and amount of antibodies present
ABOi TherapiesABOi Therapies
Plasmapheresis- remove antibodiesImmunoglobulin-decrease antibodies
which are destructive to the graftSplenectomyAnti-CD20 Antibody (rituximab)-
depletes CD20 protein which is found on the wall of most B cells
Paired DonationPaired Donation
Initially slow to take off because 1984 NOTA “unlawful to acquire organ in exchange for valuable consideration”
2007 Senate bill “valuable consideration does not apply to paired donation”
Donor ExchangeDonor Exchange
Recipient/donor pair have incompatible blood types
Other donor/recipient pair have incompatible blood types
Donors evaluated/accepted for donation Donor/recipient pairs “exchange” donor
kidneys Exchange is anonymous until after surgery
Paired donor exchangePaired donor exchange
Pair #1
Recip blood type = A
Donor blood type = B
B to A is not compatible
Pair #2
Recip blood type = B
Donor blood type = A
A to B is not compatible
Paired Donor ExchangePaired Donor Exchange
Pair #1 Pair #2
Recipient = A Recipient = B
Donor = B Donor = A
Blood-type incompatible Recip/Donor pairs
exchange blood-type compatible kidneys
Down Side of Paired DonationDown Side of Paired Donation
If one living donor backs out then the other pair is disadvantaged
Requires simultaneous O.R. start
Donor Exchange “Chains”Donor Exchange “Chains”
Participation of multiple pairs of donors and recipients
Usually started by a non-directed or “altruistic”
One donor is “left over” to begin a new section of the chain
Donor ChainsDonor Chains
Living donor can donate local to where they live
Kidneys are shipped using established OPO protocols on commercial flights
Do not need simultaneous O.R. start times
Donor ChainsDonor Chains
Very time intensive, high work load for low yield
Only about 120 done to datePotential for 1,000 -2,000 additional
kidney transplants per yearIf there is a delay in donation, donor
may back out
In short, there are new optionsIn short, there are new options
“Standard” living donor transplantHighly-sensitizedBlood-type incompatiblePaired or triple exchangeDonor exchange “chains”
ConclusionConclusion
Timely referral to transplant center Communication and collaboration between
the referring physician, patient, dialysis unit and the transplant team are the key
Advances in living donation are providing patients with more opportunities for transplant
Question to Run on?Question to Run on?
What can you do to educate your patients or community on the Journey to Transplant?
3 minutes to work at your tables and report back, Go!
Transition to LunchTransition to Lunch
Lunch is from 12:30 – 1:30
In the Crystal Ballroom, on the main level of the hotel
Open seating
Bon Appétit!